For the quarter ending 2026-03-31, AMAL had -$111,489K decrease in cash & cash equivalents over the period. $50,697K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net gain on repurchase of subordinated debt | - | 0 | 0 | 0 |
| Net income | 25,223 | 26,640 | 26,790 | 51,017 |
| Depreciation and amortization | 1,991 | 5,505 | 108 | 609 |
| Amortization of intangible assets | 105 | 143 | 144 | 287 |
| Deferred income tax expense | 1,053 | -4,109 | 2,785 | 3,001 |
| Provision for credit losses | 13,488 | 5,536 | 5,301 | 5,486 |
| Stock-based compensation expense | 2,037 | 1,983 | 1,778 | 3,157 |
| Net (gain) loss from equity method investments | 624 | 127 | 598 | -2,458 |
| Net loss on sale of securities available for sale and other assets | -822 | -485 | -1,225 | -1,721 |
| Net gain on sale of loans and change in fair value on loans held-for-sale, net | 12 | -3,640 | 70 | 850 |
| Net gain on death benefits of bank-owned life insurance | 681 | 0 | 402 | 160 |
| Proceeds from sales of loans originated as held for sale | 1,685 | 8,392 | 11,429 | 9,206 |
| Originations of loans held for sale | 458 | 8,067 | 11,441 | 10,624 |
| Increase in cash surrender value of bank-owned life insurance | 641 | 652 | 648 | 1,262 |
| Decrease in accrued interest receivable | -8,880 | 8,064 | 1,555 | -5,663 |
| Decrease in other assets | -18,194 | 1,405 | 651 | -1,200 |
| Increase in other liabilities | -14,286 | 7,244 | 5,304 | -11,770 |
| Net cash provided by operating activities | 56,776 | 37,144 | 39,499 | 59,139 |
| Proceeds from sale of owned assets | - | 0 | 0 | 46 |
| Net increase in loans | 77,998 | 214,869 | 83,276 | 43,895 |
| Proceeds from sales of loans originated as held for investment | 470 | 38,388 | 0 | 34,844 |
| Purchase of securities available for sale | 437,602 | 203,812 | 287,862 | 473,312 |
| Purchase of securities held-to-maturity | 14,382 | 92,400 | 30,320 | 35,231 |
| Proceeds from sales of securities available for sale | 46,158 | 244,653 | 64,052 | 56,136 |
| Maturities, principal payments and redemptions of securities available for sale | 96,645 | 149,232 | 139,469 | 189,161 |
| Maturities, principal payments and redemptions of securities held-to-maturity | 20,482 | 50,712 | 84,851 | 55,293 |
| Increase in resell agreements | -17,472 | 10,294 | -1,916 | -33,299 |
| Decrease (increase) in equity method investments | - | -6,472 | - | - |
| Decrease in equity method investments | 826 | - | -820 | 914 |
| Decrease in fhlbny stock, net | 0 | -268 | 0 | -10,416 |
| Purchase of premises and equipment, net | 6,079 | -855 | 1,193 | 1,041 |
| Proceeds from redemption of bank-owned life insurance | 1,506 | 1,226 | 0 | 983 |
| Net cash used in investing activities | -387,352 | -22,019 | -117,015 | -238,985 |
| Net decrease in deposits | 228,843 | 179,272 | 36,697 | 552,667 |
| Net increase in other borrowings | 0 | -5,952 | 0 | -238,994 |
| Repurchase of subordinated debt | - | 0 | 0 | 0 |
| Common stock issued under equity programs | 750 | 150 | 204 | 1,033 |
| Redemption of aremco class b shares | - | 0 | - | - |
| Repurchase of common stock | 2,779 | 8,714 | 10,444 | 13,188 |
| Dividends paid on common stock | 5,273 | 4,190 | 4,246 | 8,767 |
| Payments related to repurchase of common stock for equity awards | 2,454 | 18 | 217 | 2,588 |
| Net cash provided by (used in) financing activities | 219,087 | 160,548 | 21,994 | 290,163 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | -111,489 | 175,673 | -55,522 | 110,317 |
| Cash, cash equivalents, and restricted cash at beginning of year | 291,217 | 115,544 | 60,749 | - |
| Cash, cash equivalents, and restricted cash at end period | 179,728 | 291,217 | 115,544 | - |
Amalgamated Financial Corp. (AMAL)
Amalgamated Financial Corp. (AMAL)